Atlas Trials

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

Clinical trial NCT00107354 · COMPLETED

Trial details

NCT number
NCT00107354
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaMyelodysplastic Syndromes
Start date
1998-12-01
Primary completion
2009-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.